Welcome and Introduction to Program Co-Chairs and Keynote Presenters, and Overview of STEMI Summit Scientific Program and Mission Statement Focus on Mortality, Bleeding, and Guidelines— Striking the Ideal Balance

Program Co-Moderators

Co-Chairman (U.K.): Jonathan Hill, MD

Co-Chairman (Germany): Prof. Dr. Christian Hamm, MD

Year 2008 ESC STEMI Guidelines: Implications for The Interventional Cardiologist—From Evidence to Recommendations and Practice
Prof. Frans Van de Werf, MD, PhD

Bleeding Management and Pharmacology for PPCI in the Setting of STEMI: Focus on Landmark Trials and Emerging Perspectives on Bleeding Management for the Catheterization Laboratory
Prof. Dr. Christian Hamm, MD

The State of STEMI: Optimal Pharmacological Strategies for Reducing Bleeding and Death Associated with Invasive Management of ST-Elevation Myocardial Infarction What Does the Landmark HORIZONS-AMI Trial Teach Us?
Roxana Mehran, MD

Switching and/or Stacking Antithrombin In STEMI and High Risk ACS: Optimal Strategies for the Interventional Cardiologist and Referring Physician Community
Jonathan Hill, MD

Optimizing Outcomes in Patients with STEMI: Mortality, Bleeding, DTB Times, and Guidelines The Approach to Regional Systems for STEMI Care—Defining the Ideal Approach to Reperfusion Therapy Based on Recent Trials
Prof. Nicolas Danchin, MD, FESC

How do We Apply New ESC STEMI Guidelines and Emerging Trial Data in STEMI to Interventional Cardiology Practice—Mortality, Bleeding, and Guideline Drivers for PPCI
Giulio Guagliumi, MD